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Summary 
Three clones of E. coli, one of which was harbouring a tetracycline resistance plasmid, were inoculated 
together into the stomach of axenic mice. Without antibiotic selective pressure, the R-Plasmid bearing strain 
became dominant in the faeces of mice, while the R-plasmid free strain was eliminated. When the R-plasmid 
bearing strain was given to mice 4 days after the inoculation with the R-plasmid free strain, it was repressed and 
remained at the stable level of 104.5 organisms per g of faeces. But a rapid spread of the R-plasmid was observed, 
tetracycline resistant bacteria become dominant within one day, and replace the tetracycline sensitive E. coli. 
The tetracycline resistance plasmid did not disadvantage the mediating strain in the gut, even in the 
absence of antibiotic pressure. In contrast Lebek and Egger (1983), studying the same strains in vitro, found that 
in a chemostat the plasmid bearing strain was overgrown by the plasmid free strain. These results strongly 
suggest that in vitro interactions between E. coli strains cannot be directly extrapolated to in vivo conditions. For 
the determination of the no-effect level of antibiotic residue on the selection of R-factor in the gut, studies should 
be made in vivo. 
 
Zusammenfassung 
Drei Stämme von Escherichia coli K12, von denen einer ein R-Plasmid trug, wurden zusammen in den 
Magen axenischer Mäuse inokuliert. Ein Stamm war plasmidfrei (Str.-R), der zweite Stamm besaß die 
chromosomale Nalidixinsäureresistenz und trug das Tetracyclinresistenzplasmid R 270 (Tet Suf), Inc F II rep. 
Der dritte Stamm (Rif-R) mit chromosomaler Resistenz gegen Rifampicin trug das Plasmid F' lac Inc F I derep. 
Ohne antibiotischen Selektionsdruck wurde der das R-Plasmid Nal-Tet-R tragende Stamm in-nerhalb eines 
Tages in den Faeces der Mäuse dominant, während der R-Plasmid-freie Stamm Str-R innerhalb von zehn Tagen 
eliminiert wurde (Fig. 1). 
Gab man den Mäusen vier Tage nach der Einimpfung des Rif-R Stammes noch zusätzlich den das R-
Plasmid tragenden Stamm Nal-Tet-R, dann wurde dieser Stamm unterdrückt, und eine konstante Zahl von 104-
105 Keimen pro Gramm Faeces wurde gefunden. Jedoch wurde eine sehr schnelle Ausbreitung des R-Plasmids 
beobachtet; die tetracyclin-resistenten Bakterien (Rif-Tet-R) wurden dominant innerhalb eines Tages und 
ersetzten den tetra-cyclinsensitiven Rif-R E. coli-Stamm (Fig. 2). Diese Rif-Tet-R Transkonjuganten wurden 
unabhângig von der Anwesenheit von Tetracyclin im Trinkwasser der Mâuse gefunden (Fig. 2B). Diese 
Ausbreitung des R-Plasmids im ükologischen System des Darmes wurde auch in Mâusen beobachtet, die eine 
komplexe Flora besaf3en, welche durch die Beimpfung der Mäuse mit einer anaeroben Verdünnung 
menschlicher Faeces erhalten wurde (Fig. 3). Diese Tetracyclin-R Plasmide schienen dem Trägerstamm einen 
klaren Wuchsvorteil im Verdauungstrakt zu verleihen, sogar in Abwesenheit von antibiotischem Druck. Im 
Gegensatz dazu hatten Lebek u. Egger (1983) mit denselben Stämmen bei in vitro Versuchen im Chemostat 
gefunden, dag der plasmidtragende Stamm vom plasmidfreien Stamm über-wachsen wurde. Diese Resultate 
weisen deutlich daraufhin, dag in vitro gemessene Austausche zwischen E. coli-Stämmen nicht direkt 
übertragbar sind auf in vivo Bedingungen. Zur Bestimmungg der Antibiotikarückstandskonzentration, die keine 
Selektion von R-Fak-toren un menschlichen Darm bewirkt, sollten in vivo-Studien durchgeführt werden, ent-
weder mit Probanden oder in einem besonders für die Fragestellung geeigneten Tierversuch-smodell. 
 
Introduction 
 
Antibiotics are used in food animal production for the treatment and prevention of disease. This could 
result in the occurrence of residues in meat or milk if witholding times are not adhered to. The question of 
whether or not such residues select for intestinal bacteria bearing R-plasmids therefore arises. 
Lebek and Egger (7) investigated the minimum R-factor selecting tetracycline concentration in an in 
vitro model. Three clones of Escherichia coli, one of which was harbouring a tetracycline resistance plasmid, 
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were grown together in a chemostat, in the presence of various tetracycline concentrations. In this simple model, 
0.25 µg tetracycline/ml of medium was enough to favour the selection of the tetracycline resistant strain. Since in 
vitro methods may not reflect conditions in vivo, an attempt was made to validate this model, by inoculating 
axenic mice per os with the three strains. 
 
Materials and Methods 
The strains, provided by Professor Lebek, were three E. coli K12 921 lac-, chromosomally resistant to 
streptomycin or nalidixic acid or rifampicin. The streptomycin resistant strain was plasmid free, the nalidixic 
acid resistant strain harboured a tetracycline resistance plasmid R 270 (Tet, Suf) IncFII rep, and the rifampicin 
resistant strain a plasmid R- F' lac+ IncFI derep (7). Each strain was kept at -25°C in a broth containing 45% 
glycerol, and for the tetracycline resistant strain 10 µg/ml of tetracycline. It was then cultured overnight at 37°C 
in a nutrient broth, and diluted in phosphate buffer (KH2PO4 0.75 mg/ml, K2HPO4 3 mg/ml) on the basis of its 
optical density (400 nm, Spectrophotometer Uvikon 820, Kontron), to a concentration of 2 x 104 E. coli per ml 
of inoculum. The inoculum was buffered in order to avoid destruction of viable bacteria by the stomachal acidity 
(5). Number of viable E. coli and resistance pattern were checked a posteriori in the inoculum. The transfer 
frequency of plasmid R 270 was measured in vitro to confirm the repression of fertility. In standardized 
conditions of transfer (10) a transfer frequency of 3 x 10-4 was found, which is normal for a repressed plasmid. 
The axenic mice, adult female OF1 (Iffa Credo, F 69210 St Germain) were maintained in plastic 
isolators(La Calhene, F 95870 Bezons). A commercial diet sterilized by a 4 Mrad irradiation (Diet C04, UAR, F 
91360 Villemoisson), and autoclaved acidified water were both available ad libitum. The water was brought to 
pH 2.5 with HCI in order to avoid bacterial multiplication and tetracycline degradation in the drinking bottle. 
Each experiment was conducted in three mice, which were maintained in individual cages in one isolator. After 
confirmation of their axenic status, the mice were given 0.5 ml of the inoculum, which was administered by 
gavage directly into the stomach.  
Freshly passed faeces were collected directly at the anus, and after decimal dilution in sterile saline, 
were plated within 30 minutes onto desoxycholate agar (Difco) which contained either no antibiotic or the 
following: streptomycin (1 mg/ml), nalidixic acid (50 µg/ ml), rifampicin (100 µg/ml), tetracycline (20 µg/ml) or 
a combination of tetracycline with streptomycin, nalidixic acid or rifampicin (all antibiotics came from Sigma). 
A preliminary experiment had shown that there was no toxic synergy against the resistant strains between this 
selective medium and these antibiotic concentrations. 
 
Results 
Axenic mice were inoculated with the three strains simultaneously, which became established and were 
non-pathogenic. On two sequential experiments, the nalidixic acid-tetracycline resistant strain became dominant 
and the streptomycin resistant strain was eliminated (Fig. 1). The in vivo interactions between the three strains 
were very different from the results obtained in vitro, where the plasmid-bearing strains were repressed by the 
plasmid-free strain (7). 
 
Fig. 1. Competition between three isogenic strains of E. coli in 
gnotobiotic mice. Each point represents the mean log number of 
CFU/g faeces from three mice. 
Black triangles: nalidixic acid-tetracycline-R, Empty squares:  
rifampicin-R, Empty circles: streptomycin-R, i: inoculation. 
 
When the nalidixic acid-tetracycline resistant strain 
was given to mice four days after inoculation with the 
rifampicin resistant strain and the streptomycin resistant strain, 
it was repressed. This antagonistic effect was not observed 
when mice colonised by the streptomycin resistant strain alone 
were inoculated with the nalidixic acid-tetracycline resistant 
strain. The latter became dominant five days after introduction into the monoxenic mice. In contrast, the 
rifampicin resistant strain, already established alone in the mice, was able to antagonize subsequent infection 
with the nalidixic acid-tetracycline resistant strain. On each of four experiments, the same equilibrium was 
reached of 109.5 rifampicin resistant and 104.5 nalidixic acid-tetracycline resistant organisms per g of faeces. This 
system was stable and reproducible and seemed to be a suitable model in which to determine the minimum 
tetracycline concentration in the drinking water which would select the tetracycline resistance plasmid. 
 
Mice containing only the rifampicin resistant strain were given tetracycline continuously in the drinking 
water at concentrations of 1, 4, and 16 µg/ml and then challenged orally with the nalidixic acid-tetracycline 
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resistant strain. The administration of tetracycline did not influence the number of nalidixic acid-tetracycline 
resistant bacteria in faeces (Fig. 2A). When faecal dilutions were plated on agar containing tetracycline and 
rifampicin, it was found that a rifampicin resistant strain that carried the tetracycline resistance plasmid had 
evolved after the introduction of the nalidixic acid-tetracycline resistant strain into the ecosystem. This strain 
became dominant, and replaced the tetracycline-sensitive rifampicin resistant strain. This rapid spread of the R-
plasmid occurred independently of the presence of tetracycline in the drinking water (Fig. 2B). These 
transconjugants had not been observed in the in vitro model (7). 
 
 
Fig. 2. Effect of tetracycline on the interaction 
between two E. coli strains in gnotobiotic mice.  
2A: tetracycline (16 µg/ml) was added into the 
drinking water at day 3.  
2B: No tetracycline in the water.  
See Fig. 1 for symbols, except  
Solid black squares: rifampicin-tetracycline-R. 
 
In the presence of a more complex flora, 
obtained from the anaerobic 10-6 dilution of human 
faeces (chosen because it harboured less than 106 
coliforms per g), given together with the rifampicin 
resistant strain to axenic mice on two consecutive 
days, the number of rifampicin resistant E. coli decreased from 109.5 to 107 as shown in Fig.3. Again, the 
tetracycline resistance plasmid spread to the rifampicin resistant strain after the introduction of the nalidixic 
acid-tetracycline resistant strain, in the absence of tetracycline selective pressure. This occurred less quickly, 
however, than in the previous experiment (see Fig. 3). 
 
Fig. 3. Competition between two E. coli strains in 
gnotobiotic mice, in the presence of a human faecal flora.  
See. Fig. 2 for symbols +---+: total counts (anaerobic). 
 
Control experiments were realized, in which the 
plasmid bearing tetracycline resistant strain was replaced by 
a cured strain, obtained from the action of acridine orange 
on the nalidixic acid-tetracycline resistant strain. The 
inoculation of the three strains together led to the 
domination of the nalidixic acid resistant strain (tetracycline 
susceptible) over the other strains, the kinetics of the three 
populations being exactly the same as in Fig. 1. The 
experiment which is shown in Fig. 2B, i.e. inoculation of 
the nalidixic acid resistant strain three days after the rifampicin resistant strain, was repeated with the cured 
strain. Obviously, no tetracycline resistant transconjugants appeared, and an equilibrium was reached of 109.5 
rifampicin resistant and 107.5 nalidixic acid resistant organisms per g of faeces. 
 
Discussion 
There is a general agreement that in vitro results cannot be simply extrapolated to the in vivo situation. 
The results presented in this paper confirm this in a well control-led system: (i) the chromosomal resistance 
markers seemed to have no effect on the in vitro behaviour of the three E. coli strains (7) but played a major role 
in the in vivo interactions between the same strains (the nalidixic acid resistant strain overcame by far the 
streptomycin resistant strain), and (ii) the R-plasmid appeared to confer a disadvantage to the mediating strain in 
vitro, but gave no clear ecological disadvantage in the digestive tract (the nalidixic acid resistant strain reached 
the same level if it was plasmid free or harbouring a R-plasmid, in the presence of the two other strains, cf. Fig. 
1). 
An explanation for this discrepancy between in vitro and in vivo results comes from the differences in 
the ecological conditions: In the rich oxygenated broth of the chemostat, the shorter generation time (32 min) of 
the plasmid free strain allows it to overgrow the plasmid bearing strains (generation time of 42 min) (7). In 
contrast, in the distal part of digestive tract, where little oxygen and nutrients are available, generation times are 
usually estimated to range between 4 and 12 h, and other factors may have greater importance, such as 
attachment to the gut wall or metabolic efficiency in a limiting substrate (5). Although plasmids are important 
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determinants of the bacterial ecology, little is known about the colonisation factors they encode. According to 
Richmond (9), most plasmid bearing strains are disadvantaged against their plasmid free counterparts, likely 
because of a reduction in the in vivo growth rate. The factor which may explain the lower in vivo growth rate of 
plasmid bearing bacteria, is a higher saturation constant for limiting substrate (6), itself likely due to the cost of 
expressing the plasmidic genes in proteins, which is much more expensive than the energetic cost of duplicating 
the plasmidic DNA. The presence of a plasmid may sometimes have the opposite effect as well, i.e. to increase 
the in vivo fitness of a bacterium, likely because of adhesion to the gut wall, the proteic adhesins being often 
encoded by plasmid. For example, Duval-Iflah and others (3, 4) showed that in gnotobiotic mice, gnotobiotic 
piglets, and in human neonates, plasmid free strains generally inhibited the establishment of plasmid bearing 
strains. They found on one occasion, however, a tetracycline resistance plasmid which gave an ecological 
advantage to the strains bearing it. Therefore, whilst it has already been reported, the type of interaction 
presented here seems to be a rare occurrence. 
We are now going to discuss the design of the experimental model: Numerous authors (e.g. 6, 10) have 
studied R-factor transfer in gnotobiotic animals. Their results have also shown that plasmid transfer can take 
place in vivo without antibiotic pressure. It is important to consider this phenomenon, which was not observed in 
vitro by Lebek and Egger (7) at their detection level (105 CFU/ml), in the development of any model designed to 
assess antimicrobial safety in vivo. A possible explanation for the lack of R-plasmid transfer in vitro is that the 
coculture was made for seven hours in the chemostat (7), whereas experiments in mice were conducted for 
several days. It was not possible in our experimental model to study the early evolution of faecal flora, since the 
first positive sample arrived at the anus of the mice about eight hours after inoculation in the stomach. To our 
opinion, long term experiments simulate much better the normal human gut bacterial interactions than short term 
ones. Another explanation for the difference in the R-plasmid transfer between the continuous flow culture and 
the gut is that the total number of E. coli in the gut is much higher (109.5) than in the chemostat (107). When the 
experimental data from in vitro and in vivo models were gathered together in a mathematical model of the 
plasmid transfer (2, 6), and simulated numerically on a computer, it was found that this difference in the number 
of potential recipient bacteria was alone sufficient to explain the differences observed in the transfer rates. 
The competition between isogenic E. coli strains in vivo, differing in their chromosomal pattern of 
resistance, had also been studied. Onderdonk and others (8) showed that chromosomal resistance are detrimental 
to E. coli. It was clear in the results obtained here from the use of the cured nalidixic acid resistant strain, that the 
chromosomal resistance to streptomycin was much more detrimental in vivo to the bacteria than the resistance to 
nalidixic acid. The presence of both types of resistance (namely plasmidic and chromosomal) together in the 
same experiment was found to be rather confusing, and, in the author's opinion, this kind of marker should be 
avoided in further studies. 
The faecal human microflora given to the mice, has an antagonistic effect against the E. coli population 
(see Fig. 3), and seems to simulate the bacterial interactions of the human intestine. This kind of ecological 
situation must be a better model of the digestive tract than the mice harbouring only E. coli strains. It should 
nevertheless be explored more deeply, particularly in order to obtain a well defined and reproducible anaerobic 
flora, as Freter and others (5, 6) did with the mouse microflora. 
From the point of view of the determination of the no-effect level of an antibiotic residue on the 
selection of R-factor in the gut, studies should be made in vivo. Axenic mice, inoculated with bacteria of human 
origin may be a suitable test system (1). Experiments in human volunteers may also to be useful, though the 
natural variation in the components of the gut flora, due to contaminations or diet modifications, may hide the 
effect of low levels of antibiotics. 
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